ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction

por Schauer, Antje, Draskowski, Runa, Jannasch, Anett, Kirchhoff, Virginia, Goto, Keita, Männel, Anita, Barthel, Peggy, Augstein, Antje, Winzer, Ephraim, Tugtekin, Malte, Labeit, Siegfried, Linke, Axel, Adams, Volker
Publicado 2020

Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF

por Schauer, Antje, Adams, Volker, Augstein, Antje, Jannasch, Anett, Draskowski, Runa, Kirchhoff, Virginia, Goto, Keita, Mittag, Jeniffer, Galli, Roberta, Männel, Anita, Barthel, Peggy, Linke, Axel, Winzer, Ephraim B.
Publicado 2021

Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility

por Adams, Volker, Schauer, Antje, Augstein, Antje, Kirchhoff, Virginia, Draskowski, Runa, Jannasch, Anett, Goto, Keita, Lyall, Gemma, Männel, Anita, Barthel, Peggy, Mangner, Norman, Winzer, Ephraim B., Linke, Axel, Labeit, Siegfried
Publicado 2022